133 related articles for article (PubMed ID: 16465380)
1. Obesity, adipokines, and prostate cancer (review).
Baillargeon J; Rose DP
Int J Oncol; 2006 Mar; 28(3):737-45. PubMed ID: 16465380
[TBL] [Abstract][Full Text] [Related]
2. The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression.
Kashiwagi E; Kawahara T; Kinoshita F; Shiota M; Inokuchi J; Miyamoto H; Eto M
Anticancer Res; 2024 Apr; 44(4):1369-1376. PubMed ID: 38537999
[TBL] [Abstract][Full Text] [Related]
3. An Overview of Recent Findings that Shed Light on the Connection between Fat and Cancer.
Pandit P; Shirke C; Bhatia N; Godad A; Belemkar S; Patel J; Zine S
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):178-193. PubMed ID: 37489790
[TBL] [Abstract][Full Text] [Related]
4. Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes.
Liu CW; Peng HY; Siao AC; Tsuei YW; Lin YY; Shiah SG; Shih LJ; Yeh CC; Lee SW; Kao YH
Exp Biol Med (Maywood); 2023 Oct; 248(20):1695-1707. PubMed ID: 37646261
[TBL] [Abstract][Full Text] [Related]
5. Relationships of body composition and adipocytokines with outcomes in metastatic castration-resistant prostate cancer patients receiving docetaxel chemotherapy.
Li JH; Zhang XM; Bian XJ; Gu WJ; Wan FN; Dai B; Ye DW
Asian J Androl; 2023; 25(4):520-527. PubMed ID: 36629156
[TBL] [Abstract][Full Text] [Related]
6. Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario.
Cancel M; Pouillot W; Mahéo K; Fontaine A; Crottès D; Fromont G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142673
[TBL] [Abstract][Full Text] [Related]
7. White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.
Saha A; Hamilton-Reeves J; DiGiovanni J
Cancer Metastasis Rev; 2022 Sep; 41(3):649-671. PubMed ID: 35927363
[TBL] [Abstract][Full Text] [Related]
8. Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines.
Perego S; Sansoni V; Ziemann E; Lombardi G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670492
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer.
Kawan MA; Kyrou I; Ramanjaneya M; Williams K; Jeyaneethi J; Randeva HS; Karteris E
Oncol Rep; 2019 Feb; 41(2):1140-1150. PubMed ID: 30483810
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy.
Kang M; Byun SS; Lee SE; Hong SK
World J Mens Health; 2018 Jan; 36(1):57-65. PubMed ID: 29299904
[TBL] [Abstract][Full Text] [Related]
11. Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.
Kumar NB; Patel R; Pow-Sang J; Spiess PE; Salup R; Williams CR; Schell MJ
Oncotarget; 2017 Nov; 8(58):99093-99103. PubMed ID: 29228755
[TBL] [Abstract][Full Text] [Related]
12. KIF7 attenuates prostate tumor growth through LKB1-mediated AKT inhibition.
Wong KY; Liu J; Chan KW
Oncotarget; 2017 Aug; 8(33):54558-54571. PubMed ID: 28903364
[TBL] [Abstract][Full Text] [Related]
13. Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter.
Otunctemur A; Dursun M; Ozer K; Horsanali O; Ozbek E
Int Braz J Urol; 2016; 42(5):955-959. PubMed ID: 27532115
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin inhibits VEGF-A in prostate cancer cells.
Gao Q; Zheng J; Yao X; Peng B
Tumour Biol; 2015 Jun; 36(6):4287-92. PubMed ID: 25586350
[TBL] [Abstract][Full Text] [Related]
15. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.
Faruk Aykan N; Yildiz I; Sen F; Kilic L; Keskin S; Ciftci R; Karabulut S; Sakar B; Disci R
Med Oncol; 2013; 30(3):679. PubMed ID: 23921648
[TBL] [Abstract][Full Text] [Related]
16. Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.
Fowke JH; Motley S; Dai Q; Concepcion R; Barocas DA
Cancer Lett; 2013 Jan; 328(2):345-52. PubMed ID: 23079532
[TBL] [Abstract][Full Text] [Related]
17. Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet.
Lu YP; Lou YR; Bernard JJ; Peng QY; Li T; Lin Y; Shih WJ; Nghiem P; Shapses S; Wagner GC; Conney AH
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9065-70. PubMed ID: 22615388
[TBL] [Abstract][Full Text] [Related]
18. Insulin prevents leptin inhibition of RM1 prostate cancer cell growth.
Ribeiro AM; Pereira S; Andrade S; Costa M; Lopes C; Aguas AP; Monteiro MP
Pathol Oncol Res; 2012 Apr; 18(2):499-507. PubMed ID: 22113454
[TBL] [Abstract][Full Text] [Related]
19. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?
Steffens S; Grünwald V; Ringe KI; Seidel C; Eggers H; Schrader M; Wacker F; Kuczyk MA; Schrader AJ
Oncologist; 2011; 16(11):1565-71. PubMed ID: 22020210
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue-derived progenitor cells and cancer.
Zhang Y; Bellows CF; Kolonin MG
World J Stem Cells; 2010 Oct; 2(5):103-13. PubMed ID: 21607127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
